TP53 and colorectal carcinoma: To follow up the transcriptomics-based investigations, we next evaluated the effects of combining an IC50 (72 h) dose of MLN4924 (30 nM) with a focused panel of small interfering RNAs (siRNAs) targeting established p53-dependent and -independent regulators of cell death in the HCT116 CRC cell line.